- Home
- STRO vs FOFO Comparison
STRO vs FOFO Comparison
Compare STRO & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | FOFO |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 85.2M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | STRO | FOFO |
|---|---|---|
| Price | $11.82 | $6.34 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $18.29 | N/A |
| AVG Volume (30 Days) | ★ 101.4K | 59.4K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $105,646,000.00 | $3,117,608.00 |
| Revenue This Year | $63.08 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.88 |
| Revenue Growth | N/A | ★ 1597.65 |
| 52 Week Low | $5.23 | $4.63 |
| 52 Week High | $21.50 | $68.00 |
Technical Indicators
Market Signals| Indicator | STRO | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 75.24 | N/A |
| Support Level | $10.15 | N/A |
| Resistance Level | $12.18 | N/A |
| Average True Range (ATR) | 0.93 | 0.00 |
| MACD | -0.19 | 0.00 |
| Stochastic Oscillator | 85.66 | 0.00 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.